MEDX:NSD-Horizon Kinetics Medical ETF (USD)

ETF | Others |

Last Closing

USD 27.965

Change

+0.66 (+2.43)%

Market Cap

N/A

Volume

2.40K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

-0.80 (-1.43%)

USD 59.02B
QQQM Invesco NASDAQ 100 ETF

+0.95 (+0.44%)

USD 38.66B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.23 (+0.40%)

USD 20.93B
ACWI iShares MSCI ACWI ETF

+0.59 (+0.49%)

USD 19.52B
CGABL The Carlyle Group Inc. 4.625% ..

+0.02 (+0.11%)

USD 16.14B
NVDL GraniteShares 1.5x Long NVDA D..

+5.01 (+10.47%)

USD 4.90B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.02 (+0.04%)

USD 4.78B
TSLL Direxion Shares ETF Trust - Di..

-1.77 (-7.09%)

USD 4.68B
ETHA iShares Ethereum Trust ETF

+0.23 (+1.09%)

USD 3.75B
USCL iShares Climate Conscious & Tr..

N/A

USD 2.37B

ETFs Containing MEDX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.02% 85% B 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.02% 85% B 72% C
Trailing 12 Months  
Capital Gain -3.20% 21% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.20% 18% F 39% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.01% 41% F 39% F
Dividend Return 0.01% 32% F 34% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 3.06% 88% B+ 98% N/A
Risk Adjusted Return 0.48% 32% F 34% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector